APOE and cardiovascular disorder: Carriage of ε2 is associated with higher circulating concentrations of ApoE [7], lower circulating concentrations of low-density lipoprotein cholesterol (LDL-C) [8], and a lower risk of cardiovascular disease (CVD) events [8].